Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
ACTIVE
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
MONITOR
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
ACTIVE
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
ACTIVE
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
ACTIVE
UPF Litigation
MONITOR
48Tracked
30Active
4Pending
Navigation
Abbott SCSPENDING
Nevro SCSPENDING
Cyclosporiasis OutbreakPENDING
Apple AirTagPENDING
AI Chatbot Harm
NEWMONITOR
Roundup
ACTIVE
AFFF
ACTIVE
Depo-Provera
QUIET
Talc
ACTIVE
PFAS
ACTIVE
NEC Formula
ACTIVE
Bard Hernia Mesh
ACTIVE
Covidien Hernia Mesh
ACTIVE
Camp Lejeune
ACTIVE
Paraquat
QUIET
Social Media
ACTIVE
PowerPort
ACTIVE
AngioDynamics Port
ACTIVE
EtO Sterilization
ACTIVE
Hair Relaxer
ACTIVE
Paragard
ACTIVE
Suboxone Teeth
ACTIVE
Uber Assault
ACTIVE
Lyft Assault
ACTIVE
Ozempic Gastroparesis
ACTIVE
Ozempic NAION
ACTIVE
Church Abuse
ACTIVE
1,4-Dioxane
MONITOR
Hotel Trafficking
ACTIVE
Boy Scouts
QUIET
LDS Abuse
ACTIVE
Keytruda
ACTIVE
Tylenol
ACTIVE
Assembly of God
MONITOR
Video Game Addiction
MONITOR
CA Women's Prisons
ACTIVE
Zantac
QUIET
Dupixent CTCL
MONITOR
Boston Sci. SCS
MONITOR
ByHeart Formula
MONITOR
Cartiva
ACTIVE
Roblox
ACTIVE
Sports Betting
MONITOR
Baby Food Metals
ACTIVE
Benzene Litigation
ACTIVE
Discord Abuse
ACTIVE
Social Media Sextortion
ACTIVE
UPF Litigation
MONITOR
48Tracked
30Active
4Pending
LexGenius Logo
LexGeniusYour Edge in Mass Litigation
PricingDaily DocketTrack litigations freeSign in
LexGenius

LexGenius

Your Edge in Mass Litigation

DisclaimerAcceptable UseTermsPrivacyCookie PolicySupport

© 2026 LexGenius. All rights reserved.

Early-stage / Active MDL60 eventsMedical Device

AngioDynamics Port Catheter

Medical Device · claims involving AngioDynamics and Navilyst implanted port catheter devices including SmartPort, Xcela, BioFlo, and Vortex with alleged fracture, migration, infection, and thrombosis risks

Defendant

AngioDynamics, Inc.

MDL / Track

MDL 3125

S.D. Cal.

Judge

Judge Jinsook Ohta

Plaintiffs

roughly 363 pending claims (344 per JPML's March 2, 2026 report, plus ~19 new filings tracked since)

Bellwether / Trial

No verdicts yet

Settlement Status

  • No settlement framework announced as of mid-2026
  • no global resolution expected before bellwether outcomes
Home/Torts/AngioDynamics Port Catheter
SharePost on XShare on BlueskyShare on LinkedInShare on FacebookEmail

Track litigations for free. Save this matter, capture notes, and monitor live signals.

Sign in
← Torts Case overview Litigation status Geographic exposure Key defendants Timeline Statute of limitations Live activity News PubMed openFDA Court filings

Case overview

MDL 3125 in the Southern District of California, presided over by Judge Jinsook Ohta, now exceeds 300 cases alleging that AngioDynamics and Navilyst SmartPort, Vortex, BioFlo, and Xcela port catheters suffer from a design defect causing fracture, infection, and death. Bellwether selection is underway as of 2026. The FDA issued Class I recalls of SmartPort kits in February 2021 and Vortex MP Port in September 2022.

Causation Theory

Plaintiffs allege excessive barium sulfate concentration in polyurethane and silicone catheter tubing creates an irregular surface with fissures, pits, and cracks that promotes biofilm formation and bacterial colonization, leading to bloodstream infections, sepsis, and thrombosis. High barium sulfate load is also claimed to embrittle the catheter, causing fracture and fragment migration to the heart and lungs.

Case Management Orders

Litigation status

MDL 3125 is proceeding through bellwether selection before Judge Jinsook Ohta in the Southern District of California. Each side selected nine cases by the August 4, 2026 deadline for an initial pool of 18 claims; the pool narrows to eight by December 11, 2026. First bellwether trials are not expected until mid-2028. Magistrate Judge Valerie E. Torres entered Case Management Order No. 10 in July 2026 governing Defendant Profile Form discovery disputes.

MDL Track

MDL 3125

S.D. Cal.

AngioDynamics/Navilyst port catheter products liability

344 pending

State Court Activity

Minimal; direct-filing protocol into MDL 3125 established January 27, 2025 channels nearly all new federal filings into S.D. Cal.

Geographic exposure

Nationwide litigation: 56 actions in 28 districts at MDL 3125 formation (Oct. 2024), with 23 actions in 16 districts plus 33 potential tag-alongs in 19 districts. Devices include SmartPort, Xcela, BioFlo, and Vortex. FDA 510(k) K072375 (SmartPort CT MP, cleared Dec. 2007) predicate pathway; no clinical trials required. Core defect theory: excessive barium sulfate concentration in silicone/polyurethane catheter causing surface pitting, cracking, biofilm formation, infection, fracture, and thrombosis.

  • Southern District of California

    MDL 3125 transferee district, assigned to Judge Jinsook Ohta. Five involved actions pending; PFM Medical headquartered in district. Transfer Order, JPML, Oct. 3, 2024. Centralizes 23 actions from 16 districts plus 33 potential tag-alongs in 19 districts.

  • Northern District of Ohio

    Kitchen v. AngioDynamics, Inc., 1:24-cv-00132 (N.D. Ohio June 28, 2024). SmartPort infection claim; plaintiff alleges excessive barium sulfate concentration caused catheter surface degradation, biofilm formation, and sepsis. One of 56 actions pending in 28 districts at time of MDL formation.

  • Middle District of Florida

    Active MDL 3125 tag-along jurisdiction. Multiple actions pending per JPML Schedule A.

  • Orange County, Florida / AdventHealth Orlando

    Specific implant site identified in litigation. SmartPort explantation and biofilm cultures at AdventHealth Orlando cited as critical evidence in individual cases. Device identification cards with lot numbers traceable to manufacturing batches.

  • Western District of Missouri

    Plaintiffs' preferred MDL venue; 19 movants sought centralization here. Eastern District of Missouri also listed as involved jurisdiction per JPML Schedule A.

  • Northern District of New York

    Defendants' alternative venue suggestion. AngioDynamics, Inc. headquartered in Queensbury, NY (FDA 510(k) K072375, cleared Dec. 13, 2007). Navilyst Medical also has New York ties.

  • District of Utah

    Berrett action supported MDL centralization in W.D. Missouri. One of 16 districts with original actions at MDL formation.

  • Southern District of Texas

    Active MDL 3125 tag-along jurisdiction per JPML Schedule A.

  • Northern District of Georgia

    Active MDL 3125 tag-along jurisdiction per JPML Schedule A.

  • Northern District of Illinois

    Active MDL 3125 tag-along jurisdiction per JPML Schedule A.

Key defendants

AngioDynamics, Inc.

Role: Manufacturer

Pending MDL 3125 centralization. Alabama ruling (Apr 2024) applied Comment k to defective design claims but preserved failure-to-warn AEMLD claims. Aggressive personal jurisdiction defense posture shown in D. Mass dismissals (Walters, 21-cv-1122; Mora, 21-cv-11352).

Navilyst Medical, Inc.

Role: Subsidiary

Wholly-owned subsidiary with operations controlled from AngioDynamics' New York headquarters. Named alongside parent in port-catheter complaints; jurisdictional dismissals granted based on New York principal place of business.

DefendantRoleIntelligence Note
AngioDynamics, Inc.ManufacturerPending MDL 3125 centralization. Alabama ruling (Apr 2024) applied Comment k to defective design claims but preserved failure-to-warn AEMLD claims. Aggressive personal jurisdiction defense posture shown in D. Mass dismissals (Walters, 21-cv-1122; Mora, 21-cv-11352).
Navilyst Medical, Inc.SubsidiaryWholly-owned subsidiary with operations controlled from AngioDynamics' New York headquarters. Named alongside parent in port-catheter complaints; jurisdictional dismissals granted based on New York principal place of business.

Timeline

  1. 2023-12

    Reed v. AngioDynamics Motion to Dismiss Denied

    W.D. Missouri Judge M. Douglas Harpool denied AngioDynamics' motion to dismiss in SmartPort bacteremia/sepsis case, rejecting statute of limitations and failure-to-state-a-claim arguments. Case No. 2:23-cv-04066-MDH.

  2. 2024-02

    Morris v. AngioDynamics Partial Dismissal Granted

    M.D. Alabama Judge R. Hope partially granted AngioDynamics' motion to dismiss, tossing warranty, negligent misrepresentation, fraud, and fraudulent concealment claims but preserving AEMLD and negligence/wantonness counts in SmartPort thrombosis case. Case No. 1:23-cv-00294-RAH.

  3. 2024-04

    Smith v. AngioDynamics Design Claim Dismissed

    M.D. Alabama Judge Andrew L. Brasher dismissed defective design claim under Alabama AEMLD, applying Comment k to SmartPort as 'unavoidably unsafe' medical device, but preserved failure-to-warn claim. Case No. 2:24-cv-112-RAH.

  4. 2024-06

    Kitchen v. AngioDynamics OPLA Claims Survive

    N.D. Ohio Judge Dan Aaro Polster denied in part AngioDynamics' motion to dismiss, allowing Ohio Product Liability Act claims for negligence, design defect, failure to warn, and breach of warranties to proceed in SmartPort infection case. Case No. 1:24-cv-00132.

Statute of limitations

MDL 3125 established February 2025: In re: AngioDynamics, Inc., and Navilyst Medical, Inc., Port Catheter Products Liability Litigation, S.D. Cal., Judge Jinsook Ohta. Confirmed device scope: SmartPort, Xcela, Xcela Plus, Vortex, Vortex Dual Port, BioFlo. Exclusively AngioDynamics/Navilyst—screen out Bard/BD PowerPort (MDL 3081). Missouri poses urgent accrual risk given 'capable of ascertainment' standard and Reed dismissal pattern.

⚠ 1 state with critical SOL — act immediately

⚠Missouri

5 years from when damage is capable of ascertainment

Rule: Accrual on 'capable of ascertainment' standard per Reed dismissal; Judge M. Douglas Harpool, W.D. Mo., Dec. 8, 2023

Discovery: Missouri's 'capable of ascertainment' standard predates discovery; inquiry notice events matter

Reed dismissal held claims time-barred at 10+ years; strict accrual analysis bars delayed filings

Alabama

2 years from accrual

Rule: AEMLD claims subject to Comment k unavoidably unsafe product doctrine; Smith v. AngioDynamics, 2:24-cv-112-RAH, M.D. Ala. Apr. 23, 2024

Design defect claims likely barred under Comment k; failure-to-warn claims may survive if adequately pled

California

2 years from discovery of injury

Rule: Discovery rule applies; MDL 3125 situs, S.D. Cal. Judge Jinsook Ohta

Discovery: Discovery of injury and its cause triggers accrual

MDL 3125 transferee court; large plaintiff pool per source [1]

Texas

2 years from accrual

Rule: Tex. Civ. Prac. & Rem. Code § 16.003; tort reform limits damage awards per source [1]

Tort reform caps non-economic damages; verify device type excludes Bard/BD PowerPort

Florida

2-4 years depending on theory

Rule: Products liability 4 years, medical malpractice 2 years; tort reform limits damages per source [1]

Screening critical: implantation-related complications may trigger shorter med-mal SOL

New York

3 years from injury

Rule: N.Y. C.P.L.R. § 214(6); broader recovery allowed per source [1]

Discovery: Discovery of injury triggers accrual

Large plaintiff concentration; no damages cap

Pennsylvania

2 years from discovery

Rule: 42 Pa. C.S. § 5524; significant plaintiff volume per source [1]

Discovery: Accrual upon discovery of injury and causation

No economic damages cap; no statute of repose

StateSOLRuleDiscovery RuleNotes
⚠Missouri5 years from when damage is capable of ascertainmentAccrual on 'capable of ascertainment' standard per Reed dismissal; Judge M. Douglas Harpool, W.D. Mo., Dec. 8, 2023Missouri's 'capable of ascertainment' standard predates discovery; inquiry notice events matterReed dismissal held claims time-barred at 10+ years; strict accrual analysis bars delayed filings
Alabama2 years from accrualAEMLD claims subject to Comment k unavoidably unsafe product doctrine; Smith v. AngioDynamics, 2:24-cv-112-RAH, M.D. Ala. Apr. 23, 2024—Design defect claims likely barred under Comment k; failure-to-warn claims may survive if adequately pled
California2 years from discovery of injuryDiscovery rule applies; MDL 3125 situs, S.D. Cal. Judge Jinsook OhtaDiscovery of injury and its cause triggers accrualMDL 3125 transferee court; large plaintiff pool per source [1]
Texas2 years from accrualTex. Civ. Prac. & Rem. Code § 16.003; tort reform limits damage awards per source [1]—Tort reform caps non-economic damages; verify device type excludes Bard/BD PowerPort
Florida2-4 years depending on theoryProducts liability 4 years, medical malpractice 2 years; tort reform limits damages per source [1]—Screening critical: implantation-related complications may trigger shorter med-mal SOL
New York3 years from injuryN.Y. C.P.L.R. § 214(6); broader recovery allowed per source [1]Discovery of injury triggers accrualLarge plaintiff concentration; no damages cap
Pennsylvania2 years from discovery42 Pa. C.S. § 5524; significant plaintiff volume per source [1]Accrual upon discovery of injury and causationNo economic damages cap; no statute of repose

Live intelligence

AI litigation brief

AngioDynamics Port Catheter remains early-stage / active mdl with 60 current signals in the accepted feed.

Overview

MDL 3125 is proceeding through bellwether selection before Judge Jinsook Ohta in the Southern District of California. Each side selected nine cases by the August 4, 2026 deadline for an initial pool of 18 claims; the pool narrows to eight by December 11, 2026. First bellwether trials are not expected until mid-2028. Magistrate Judge Valerie E. Torres entered Case Management Order No. 10 in July 2026 governing Defendant Profile Form discovery disputes.

Key developments

  • PACER court filing on Sep 25: AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation
  • AboutLawsuits.com news on Aug 21: AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter Design - AboutLawsuits.com
  • MAUDE FDA alert on Aug 31: MAUDE Filing 50515046: Xcela
  • PubMed research on Sep 18: The Transcaval AngioVac Aspiration of a Left Subclavian Artery Intimal Sarcoma Masquerading as Arterial Thrombosis: A Case Report.

Trajectory

Court filings and press coverage are both active in MDL 3125, pointing to sustained litigation pressure rather than a one-off headline cycle. 14 live sources are contributing current context.

Editorial intelligence

MDL 3125 should stay on the lead docket watch because it is the primary consolidation vehicle for AngioDynamics Port.

Generated Sep 30, 2026, 10:00 AM UTC

60 events detected

Google News (10)

  • AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter Design - AboutLawsuits.com

    AboutLawsuits.comAug 21, 2026, 1:00 PM UTC
  • AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter - AboutLawsuits.com

    AboutLawsuits.comAug 21, 2026, 7:00 AM UTC
  • AngioDynamics SmartPort Infection Lawsuit Alleges Defective Port Caused Sepsis - aboutlawsuits.com

    aboutlawsuits.comAug 7, 2026, 7:00 AM UTC
  • Port Catheter Sepsis Lawsuit Claims Defective SmartPort Implant Caused Infection - aboutlawsuits.com

    aboutlawsuits.comJul 22, 2026, 7:00 AM UTC
  • SmartPort Catheter Lawsuit Claims Defective AngioDynamics Port-a-Cath Caused Infection - aboutlawsuits.com

    aboutlawsuits.comJul 14, 2026, 7:00 AM UTC
  • Vortex Port Lawsuit Claims Defective AngioDynamics Device Caused Infection, Pulmonary Embolism - aboutlawsuits.com

    aboutlawsuits.comJul 7, 2026, 7:00 AM UTC
  • AngioDynamics Port Catheter Lawsuit Claims Woman’s SmartPort Implants Caused Multiple Infections - aboutlawsuits.com

    aboutlawsuits.comJun 23, 2026, 7:00 AM UTC
  • Xcela Port Lawsuit Claims AngioDynamics Catheter Caused Thrombosis - aboutlawsuits.com

    aboutlawsuits.comJun 12, 2026, 7:00 AM UTC
  • Port Catheter Thrombosis Lawsuit Claims Defective AngioDynamics Xcela Device Caused Injury - aboutlawsuits.com

    aboutlawsuits.comJun 3, 2026, 7:00 AM UTC
  • SmartPort Surgery Lawsuit Claims AngioDynamics Catheter Fractured Inside Woman’s Body - aboutlawsuits.com

    aboutlawsuits.comMay 15, 2026, 7:00 AM UTC
StudyPubMed
Detected Sep 30, 2026, 10:07 AM UTC

The Transcaval AngioVac Aspiration of a Left Subclavian Artery Intimal Sarcoma Masquerading as Arterial Thrombosis: A Case Report.

Reports (MDPI) • Baković Kramarić D • PMID 42784040 • Case Reports.

Confidence 74%Published Sep 18, 2026, 12:00 AM UTCSource →
StudyPubMed
Detected Sep 30, 2026, 10:07 AM UTC

Percutaneous Thrombectomy of a Thrombus in Transit Through a Patent Foramen Ovale: A Novel Approach.

JACC. Case reports • Aoun J • PMID 42726037 • Case Reports.

Confidence 74%Published Sep 10, 2026, 12:00 AM UTCSource →
StudyPubMed
Detected Sep 30, 2026, 10:07 AM UTC

Catheter salvage with antibiotic lock therapy for central venous port infection due to Pseudoxanthomonas sp. in a child with hemophilia B.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy • Hagiya H • PMID 42705605 • Case Reports.

Confidence 74%Published Sep 8, 2026, 12:00 AM UTCSource →
StudyPubMed
Detected Sep 30, 2026, 10:07 AM UTC

Transesophageal echocardiography-guided repositioning of a totally implantable venous access device that migrated into the left atrium across a patent foramen ovale.

The journal of vascular access • Romero-Vanegas N • PMID 42610556 • Journal Article.

Confidence 74%Published Aug 18, 2026, 12:00 AM UTCSource →
StudyPubMed
Detected Sep 30, 2026, 10:07 AM UTC

Complication-related Removal of Central Venous Ports: Comparison of Subclavian and Upper Arm Approaches.

Interventional radiology (Higashimatsuyama-shi (Japan) • Tsushima Y • PMID 42614291 • Journal Article.

Confidence 74%Published Jul 31, 2026, 12:00 AM UTCSource →
PACERCASD3:26-cv-05515Sep 25, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc., PFM Medical, Inc.. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21680427.), filed by Todd Webster. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5515-JO-VET. Jud

PACERCASD3:26-cv-05470Sep 23, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21668623.), filed by Christopher Hooks. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5470-JO-VET. Judge Jinsook Oht

PACERCASD3:26-cv-05437Sep 22, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24-md-3125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21663050.), filed by Cynthia Dunham Gonzalez. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5437-JO-VET. Judge Jinsoo

PACERCASD3:26-cv-05436Sep 22, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 3:24-md-3125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21663031.), filed by Francisco Albero Gruyair. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5436-JO-VET. Judge Jin

PACERCASD3:26-cv-05379Sep 18, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc.. Related to MDL Case - 3:24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21651270.), filed by Denise Kneisler. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5379-JO-VET. Judge Jinsook Ohta and Magistrate Judge V

PACERCASD3:26-cv-05341Sep 16, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24-md-03125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21641281.), filed by Sandra Lynn Royer. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5341-JO-VET. Judge Jinsook Oht

PACERCASD3:26-cv-05309Sep 15, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc. ( Filing fee $ 405 receipt number ACASDC-21637950.), filed by Toni Yates. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5309-JO-VET. Judge Jinsook Ohta and Magistrate Judge Valerie E. Torres are assig

PACERCASD3:26-cv-05298Sep 15, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 3:24-md-3125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21635577.), filed by Pattie Lynn Colwell. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5298-JO-VET. Judge Jinsook

PACERCASD3:26-cv-05290Sep 14, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24md3125. ( Filing fee $ 405 receipt number ACASDC-21632289.), filed by Tiffany Rodeina Summers. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5290-JO-VET. Judge Jinsook Ohta an

PACERCASD3:26-cv-05244Sep 11, 2026, 12:00 AM UTC

AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation

PACER docket entry from CASD: COMPLAINT with Jury Demand against Angiodynamics, Inc., Navilyst Medical, Inc.. Related to MDL Case - 24-md-3125-JO-VET. ( Filing fee $ 405 receipt number ACASDC-21622489.), filed by Samantha Ashley Bigot. (Attachments: # 1 Civil Cover Sheet)The new case number is 3:26-cv-5244-JO-VET. Judge Jinsook

Sign in to view all 18 filings

Workbench

Sign in to save litigations, capture notes, and monitor live signals. Sign in for unlimited.

LexGenius Ranking

92Score

Court, news, and regulatory activity are elevated

Evidence20 / 20
Momentum20 / 20
Exposure16 / 20
Regulatory16 / 20
Legal20 / 20

Monitoring

Live

monitoring

Last: Sep 30, 2026, 10:00 AM UTC

Next: —

Source Monitoring

PACER

38s

PACER

38s

Google News

38s

MAUDE

38s

PubMed

15m 38s

Event feed

60

events detected

Google NewsPACERMAUDEPubMed

AI Brief

AngioDynamics Port Catheter remains early-stage / active mdl with 60 current signals in the accepted feed.

Overview

MDL 3125 is proceeding through bellwether selection before Judge Jinsook Ohta in the Southern District of California. Each side selected nine cases by the August 4, 2026 deadline for an initial pool of 18 claims; the pool narrows to eight by December 11, 2026. First bellwether trials are not expected until mid-2028. Magistrate Judge Valerie E. Torres entered Case Management Order No. 10 in July 2026 governing Defendant Profile Form discovery disputes.

Key developments

PACER court filing on Sep 25: AngioDynamics Inc. and Navilyst Medical Inc. Port Catheter Products Liability Litigation. ‖ AboutLawsuits.com news on Aug 21: AngioDynamics Xcela Port Lawsuit Alleges Infection, Migration Caused by Defective Catheter Design - AboutLawsuits.com. ‖ MAUDE FDA alert on Aug 31: MAUDE Filing 50515046: Xcela. ‖ PubMed research on Sep 18: The Transcaval AngioVac Aspiration of a Left Subclavian Artery Intimal Sarcoma Masquerading as Arterial Thrombosis: A Case Report..

Generated Sep 30, 2026, 10:00 AM UTC

Tracked MDLs

MDL 3125

S.D. Cal.

AngioDynamics/Navilyst port catheter products liability

← Previous

Bard PowerPort

Tracks PowerPort device litigation, catheter safety reporting, and related medical literature.

Next →

EtO Sterilization

Follows ethylene oxide emissions litigation, sterilization-facility enforcement, and environmental-health reporting.